<code id='C020F6D67E'></code><style id='C020F6D67E'></style>
    • <acronym id='C020F6D67E'></acronym>
      <center id='C020F6D67E'><center id='C020F6D67E'><tfoot id='C020F6D67E'></tfoot></center><abbr id='C020F6D67E'><dir id='C020F6D67E'><tfoot id='C020F6D67E'></tfoot><noframes id='C020F6D67E'>

    • <optgroup id='C020F6D67E'><strike id='C020F6D67E'><sup id='C020F6D67E'></sup></strike><code id='C020F6D67E'></code></optgroup>
        1. <b id='C020F6D67E'><label id='C020F6D67E'><select id='C020F6D67E'><dt id='C020F6D67E'><span id='C020F6D67E'></span></dt></select></label></b><u id='C020F6D67E'></u>
          <i id='C020F6D67E'><strike id='C020F6D67E'><tt id='C020F6D67E'><pre id='C020F6D67E'></pre></tt></strike></i>

          hotspot

          hotspot

          author:Wikipedia    Page View:43169

          What does Covid-19 have in store for the winter? When are good data not good enough? And how many would-be Wegovys are there?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Helen Branswell joins us to discuss the state of the Covid-19 pandemic heading into the fall and the rollout of boosters shots aimed at the latest viral variants. We also discuss the latest news in the life sciences, including an IPO implosion, a debate at the FDA, and the ups and downs of a career in biotech.

          advertisement

          For more on what we cover, here’s the latest on booster shots; here’s more on Covid-19 in 2023; here’s the news on Alnylam Pharmaceuticals; here’s more on 2Seventy Bio; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          leisure time

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          Three issues to watch in global health in 2024
          Three issues to watch in global health in 2024

          ChristineKao/STATAsweenterthefifthyearofthischallengingdecade,lifefinallyappearstobeinchingtowardnor

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          Cue Health's Covid

          BusinesswireviaAPTheFoodandDrugAdministrationwarnedconsumersMondaytonotuseCueHealth’sat-homeCovid-19